MedPath

Management of psoriasis by homoeopathy

Active, not recruiting
Conditions
Psoriasis, unspecified,
Registration Number
CTRI/2020/05/025137
Lead Sponsor
State National Homoeopathic Medical College and Hospital
Brief Summary

Followingprovision of patient information sheet and obtainment of writtenconsent , preliminary screening using inclusion criteria and exclusioncriteria, eligible patients will be recruited into the trial.

Step1- Selection of the samples (n=30), fulfilling the inclusion criteria, afterdetailed screening eligible participants will be recruited for the trial forthe period of 24 weeks.

 Step2- Proper case taking will be done, according to homoeopathic principle, in astandard case taking proforma.

 Step3- Collected symptoms are to be analyzed and evaluated according to Kent’sphilosophy of evaluation of symptoms. Miasmatic analysis will also be doneaccordingly. Following that Totality of the symptoms will be framed.

 Step4- Symptoms of totality will be converted into rubrics, and repertorization isto be done with the help of Synthesis 9.1 Repertory.

 Step5- Final selection of medicine to be done on the basis of individualization,after consultation with MateriaMedica, considering the miasmatic background ofthe patient.

 Step6- Potency and dose will be selected according to strict homoeopathicprinciple.

 Step7- Subsequent prescription will be generated according to Kent’s 12observations, second prescription and other relevant homoeopathic principles,details of follow up will be recorded carefully.

Step 8- Followup will be done at an interval of two week (15days) for a period of 24 weeks or6 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
All
Target Recruitment
30
Inclusion Criteria

diagnosed cases of psoriasis literate patients willing to give consent.

Exclusion Criteria

patient suffering from other diseases patients with complications like arthritis or psychiatry disorders patients not willing to sign consent form pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
change in PASI SCORE15DAYS
Secondary Outcome Measures
NameTimeMethod
change in DLQI SCORE15 days

Trial Locations

Locations (1)

STATE NATIONAL HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

🇮🇳

Lucknow, UTTAR PRADESH, India

STATE NATIONAL HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL
🇮🇳Lucknow, UTTAR PRADESH, India
ANJU RANI
Principal investigator
8439336136
dr.anjupanwarr@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.